In an interview with CNBC-TV18, Alok Saxena, Director (International), Elder Pharmaceuticals spoke about the performance of the company. The company is expecting its domestic formulation business to report growth of 20-25% ahead.
first published: May 10, 2011 04:31 pm
A collection of the most-viewed Moneycontrol videos.
Why India needs to rethink protectionism and bring in capital market reforms - Jahangir Aziz
Trump Hints at Big India-US Trade Deal | Moneycontrol MEGA Exclusive
Live: Davos 2026 Day 3 Highlights | AI, India Deals & Global CEO Voices
Live: Nifty recovers 150 pts from day's low in a choppy session, India VIX shoots | Closing Bell
